243 related articles for article (PubMed ID: 18411283)
1. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
Cox JH; Dean RA; Roberts CR; Overall CM
J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283
[TBL] [Abstract][Full Text] [Related]
2. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
3. Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3.
Nedjai B; Li H; Stroke IL; Wise EL; Webb ML; Merritt JR; Henderson I; Klon AE; Cole AG; Horuk R; Vaidehi N; Pease JE
Br J Pharmacol; 2012 Jun; 166(3):912-23. PubMed ID: 21895630
[TBL] [Abstract][Full Text] [Related]
4. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
7. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
Colvin RA; Campanella GS; Sun J; Luster AD
J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261
[TBL] [Abstract][Full Text] [Related]
8. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
[TBL] [Abstract][Full Text] [Related]
9. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
[TBL] [Abstract][Full Text] [Related]
10. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
11. CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.
Manousou P; Kolios G; Drygiannakis I; Koulentaki M; Pyrovolaki K; Voumvouraki A; Notas G; Bourikas L; Papadaki HA; Kouroumalis E
Clin Exp Immunol; 2013 Apr; 172(1):9-15. PubMed ID: 23480180
[TBL] [Abstract][Full Text] [Related]
12. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
Colvin RA; Campanella GS; Manice LA; Luster AD
Mol Cell Biol; 2006 Aug; 26(15):5838-49. PubMed ID: 16847335
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationship between the human chemokine receptor CXCR3 and its ligands.
Clark-Lewis I; Mattioli I; Gong JH; Loetscher P
J Biol Chem; 2003 Jan; 278(1):289-95. PubMed ID: 12417585
[TBL] [Abstract][Full Text] [Related]
14. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Loos T; Mortier A; Gouwy M; Ronsse I; Put W; Lenaerts JP; Van Damme J; Proost P
Blood; 2008 Oct; 112(7):2648-56. PubMed ID: 18645041
[TBL] [Abstract][Full Text] [Related]
15. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.
Hueso L; Ortega R; Selles F; Wu-Xiong NY; Ortega J; Civera M; Ascaso JF; Sanz MJ; Real JT; Piqueras L
Int J Obes (Lond); 2018 Aug; 42(8):1406-1417. PubMed ID: 29795466
[TBL] [Abstract][Full Text] [Related]
17. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11.
Xanthou G; Duchesnes CE; Williams TJ; Pease JE
Eur J Immunol; 2003 Aug; 33(8):2241-50. PubMed ID: 12884299
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.
Scholten DJ; Canals M; Wijtmans M; de Munnik S; Nguyen P; Verzijl D; de Esch IJ; Vischer HF; Smit MJ; Leurs R
Br J Pharmacol; 2012 Jun; 166(3):898-911. PubMed ID: 21883151
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
20. CXCR3 internalization following T cell-endothelial cell contact: preferential role of IFN-inducible T cell alpha chemoattractant (CXCL11).
Sauty A; Colvin RA; Wagner L; Rochat S; Spertini F; Luster AD
J Immunol; 2001 Dec; 167(12):7084-93. PubMed ID: 11739530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
